Differential Expression of Proteomics Models of Colorectal Cancer, Colorectal Benign Disease and Healthy Controls

DSpace/Manakin Repository

Differential Expression of Proteomics Models of Colorectal Cancer, Colorectal Benign Disease and Healthy Controls

Citable link to this page

 

 
Title: Differential Expression of Proteomics Models of Colorectal Cancer, Colorectal Benign Disease and Healthy Controls
Author: Li, Chun-Feng; Chen, Hong-Sheng; Lin, Luo-Qiang; Zhang, Chun-Peng; Zhao, Jin-Lu; Zhang, Shu-Jun; Jin, Jun-Chao; Liu, Ming; Liu, Yan; Wang, Lei; Liu, Jia-Ren

Note: Order does not necessarily reflect citation order of authors.

Citation: Liu, Ming, Chun-Feng Li, Hong-Sheng Chen, Luo-Qiang Lin, Chun-Peng Zhang, Jin-Lu Zhao, Yan Liu, et al. 2010. Differential expression of proteomics models of colorectal cancer, colorectal benign disease and healthy controls. Proteome Science 8: 16.
Full Text & Related Files:
Abstract: Background: Colorectal cancer (CRC) is often diagnosed at a late stage with concomitant poor prognosis. The hypersensitive analytical technique of proteomics can detect molecular changes before the tumor is palpable. The surface-enhanced laser desorption/ionization-time of flight-mass spectra (SELDI-TOF-MS) is a newly-developed technique of evaluating protein separation in recent years. The protein chips have established the expression of tumor protein in the serum specimens and become the newly discovered markers for tumor diagnosis. The objective of this study was to find new markers of the diagnosis among groups of CRC, colorectal benign diseases (CBD) and healthy controls. The assay of SELDI-TOF-MS with analytical technique of protein-chip bioinformatics was used to detect the expression of protein mass peaks in the sera of patients or controls. One hundred serum samples, including 52 cases of colorectal cancer, 27 cases of colorectal benign disease, and 21 cases of healthy controls, were examined by SELDI-TOF-MS with WCX2 protein-chips. Results: The diagnostic models (I, II and III) were setup by analyzed the data and sieved markers using Ciphergen - Protein-Chip-Software 5.1. These models were combined with 3 protein mass peaks to discriminate CRC, CBD, and healthy controls. The accuracy, the sensitivity and the particularity of cross verification of these models are all highly over 80%. Conclusions: The SELDI-TOF-MS is a useful tool to help diagnose colorectal cancer, especially during the early stage. However, identification of the significantly differentiated proteins needs further study.
Published Version: doi:10.1186/1477-5956-8-16
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862023/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4745736
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters